![Jia Qin Yao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jia Qin Yao
Technik-/Wissenschafts-/F&E-Leiter bei Shanghai Innostar Biotechnology Co., Ltd.
Profil
Jia Qin Yao is currently the Chief Scientific Officer & Deputy General Manager at Shanghai Innostar Biotechnology Co., Ltd.
Prior to this role, Dr. Yao obtained a doctorate degree from the University of Cincinnati (Ohio) and completed undergraduate and graduate studies at Shanghai Medical College of Fudan University.
Aktive Positionen von Jia Qin Yao
Unternehmen | Position | Beginn |
---|---|---|
Shanghai Innostar Biotechnology Co., Ltd.
![]() Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2020 |
Ausbildung von Jia Qin Yao
Shanghai Medical College of Fudan University | Graduate Degree |
University of Cincinnati (Ohio) | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Shanghai Innostar Biotechnology Co., Ltd.
![]() Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Commercial Services |